Risky Cocktails, Risky Business - PowerPoint PPT Presentation

1 / 41
About This Presentation
Title:

Risky Cocktails, Risky Business

Description:

Ecstasy (X, MDMA) 2D6 substrate (1A2,2B6,3A4) Can be lethal. ... RTV Ecstasy levels by 5-10 times. ... Ecstasy (X, MDMA) ... – PowerPoint PPT presentation

Number of Views:100
Avg rating:3.0/5.0
Slides: 42
Provided by: detroitmed
Category:

less

Transcript and Presenter's Notes

Title: Risky Cocktails, Risky Business


1
Risky Cocktails, Risky Business Drug Interactions
between Recreational Drugs and HAART
Prepared by Patricia Martin, Pharm.D.
2
HIV Therapy Today
  • Combination therapy of at least three ARV drugs
  • Medications to prevent or treat opportunistic
    infections
  • Medications to treat comorbid conditions
  • Medications to treat substance use
  • Alternative/Herbal meds
  • Investigational drugs

3
Anti-HIV Medications Street Drugs
  • For most drugs to be effective and not kill you,
    they need to be metabolized broken down by the
    liver or kidneys. These organs have limited
    resources and a set number of chemicals which
    accomplish this task. Because of this, certain
    drugs, whether they're HIV medications or
    recreational drugs, can affect how other drugs
    act.
  • This is called a drug interaction and some of
    them can be deadly.

4
Drug Interactions
  • Occurs when either the pharmacokinetics or the
    pharmacodynamics of one drug is altered by the
    administration of food or a concomitant drug
  • Factors that can exaggerate pharmacokinetic
    variability include
  • drug-drug interactions
  • drug-food interactions
  • drug-disease interactions (altered GI, renal and
    hepatic function)
  • Sex differences in patients
  • Pregnancy
  • Genetic differences in patients

5
PK Interactions
  • Absorption
  • Distribution
  • Metabolism
  • Excretion

Piscitelli SC, Gallicano KD. N Engl J Med
2001344984-96
6
PD Interactions
  • Antagonistic 1 1 0
  • AZT d4T
  • Synergistic 1 1 3
  • Hydroxyurea NRTIs
  • Additive 1 1 2
  • Overlapping toxicities

7
Drug Interactions Related to the Metabolism of
HAART
  • Medications used in HAART, especially the NNRTIs
    and PIs, are metabolized via the cytochrome P450
    enzyme system (CYP450)
  • The isoenzyme responsible for the majority of
    this metabolism is CYP3A4, although 2C19 and 2D6
    are also common.

8
Cytochrome P450 Enzymes
  • Group of heme containing enzymes responsible for
    phase 1 oxidative metabolic reaction
  • Family that detoxify compounds
  • Absorbance of light at 450 nanometers (hence
    CYP450)
  • On membranes of endoplasmic reticulum in liver,
    gut, brain, lung, kidney

9
Cytochrome P450 Nomenclature
CYP 3A4
Specific enzyme
Subfamily
Family
  • CYP Substrates
  • CYP Inducers
  • CYP Inhibitors

GENE for mammalian cytochrome
10
Effect of Antiretroviralson Drug Metabolism
3A4
2C19
2D6
2C9
1A2
2E1
2A6
2B6
2C8
Inhibited by ATV
Fichtenbaum.Clin Pharmacokinet.2002 Lafay et al.
ICAAC 2003 Product inserts
11
Medications that interact with the CYP450 system
do so in 1 of 3 ways
  • Inhibition Generally leads to decreased rates
    of metabolism of other drugs metabolized by the
    same enzyme, resulting in higher drug levels and
    increased potential for toxicity.
  • Inhibition is usually reversible, irreversible
    inhibition can occur, requiring new CYP450 enzyme
    to be synthesized.
  • Inhibition tends to occur quickly with maximal
    effect occurring when highest concentrations of
    the inhibitor are reached.
  • Example Ritonavir and Midazolam ? sedation

12
Medications that interact with the CYP450 system
do so in 1 of 3 ways
  • Induction results in the increased clearance of
    concomitant medications metabolized by the same
    enzyme.
  • The body responds by increasing the production of
    specific enzymes of the CYP450 system.
  • ? enzyme production can lead to ? metabolism and
    ? drug concentrations
  • Example Efavirenz and methadone withdrawal
    symptoms

13
Medications that interact with the CYP450 system
do so in 1 of 3 ways
  • Substrates occupy the active site of a specific
    CYP450 enzyme.
  • The medications metabolism is then affected by
    other medications that either induce or inhibit
    the CYP450 enzyme system.
  • Example NNRTIs and PIs are substrates at CYP3A4
    and are therefore prone to drug interactions.

14
Drug Interactions (Liver)
CYP Substrate
? Substrate concentration
? Toxicity
CYP Inhibitor
CYP Substrate
? Substrate concentration
? Efficacy
CYP Inducer
15
Recreational Drugs and HAART
  • There is very little data
  • No controlled trials
  • Information is largely extrapolated from in vitro
    PK experiments, case reports, or animal model
    studies.
  • Best advice is to not use the two, however, if
    you have to party make sure you know which
    combinations to avoid.

16
Ecstasy (X, MDMA)
  • 2D6 substrate (1A2,2B6,3A4)
  • Can be lethal. One case report in England
    described a fatal interaction between ritonavir
    at full dose and ecstasy (MDMA, X). Second,
    near-fatal reaction in a patients taking
    saquinavir/ritonavir (boosted dose) and a small
    dose of ecstasty. RTV ? Ecstasy levels by 5-10
    times.
  • In addition, between 3-10 of the white
    population have a 2D6 deficiency, which may be
    why some people overdose on what may be a safe
    dose for others.
  • Since the amount of X varies in each pill, it is
    difficult to know how much will put you in danger.

Source Henry JA, Hill IR. Fatal interaction
between ritonavir and MDMA. Lancet
199835217512.
17
Ecstasy (X, MDMA)
  • Clinicians should not prescribe PIs, even in low
    doses for boosting, if patients say they use
    ecstasy.
  • Patients -If you are taking any protease
    inhibitor or non-nucleoside reverse transcriptase
    inhibitor X can be extremely dangerous.
  • Of these, ritonavir and delavirdine seem to be
    the most dangerous, while nevirapine and
    efavirenz may be less soalthough effects are
    hard to predict.

18
Ecstasy (X, MDMA)
  • Recent research has found that X damages
    serotonin neurons, so avoid it if you have a
    family or personal history of depression or
    anxiety disorders.
  • If you do take X with a protease inhibitor, wait
    as long as possible after taking the protease
    inhibitor to take the X, and be sure to have
    someone with you who knows what you've done in
    case you have difficulties. These overdoses are
    often not reversible, so it's really better not
    to mix these drugs!
  • Taking X while on HAART may lead you to roll for
    much longer. Some people have reported rolling
    for 30 hours from two pills while taking
    ritonavir and saquinavir.

19
Ecstasy (X, MDMA)
Recommendations from HIV Program/Inner City
Health, St. Michael's Hospital, Toronto, Canada.
  • Use 25 of the usual amount of MDMA
  • Take breaks from dancing
  • Make sure rave or party has medical team on site
  • Maintain adequate hydration by avoiding alcohol
    and replenishing fluids regularly

Source Antoniou T, Tseng AL. Interactions
between recreational drugs and antiretroviral
agents. Ann Pharmacother 2002 Oct36(10)1598-613.
20
Amphetamines (dexedrine, amphetamine,
methamphetamine, crystal meth)
  • Amphetamines work the same way that X does in
    your body. As with X, Norvir (ritonavir) should
    be avoided.
  • Norvir is predicted to increase amphetamine
    levels in the blood by a factor of 2-3.
  • The other protease inhibitors should have less of
    an impact, but strange opposite results are
    always possible.

21
GHB,Liquid X(GABA, -aminobutyric acid, date
rape drug)
  • 2D6 substrate
  • GHB is potentially dangerous with ritonavir and
    other PIs.
  • One man had serious life-threatening conditions
    after taking a small amount of GHB to come down
    from an X trip. He was on ritonavir and
    saquinavir at the time and had taken similar does
    of the rave drugs without problems in the past.

Source Harrington RD, Woodward JA, Hooton TM,
Horn JR. Life-threatening interactions between
HIV-1 protease inhibitors and the illicit drugs
MDMA and gamma-hydroxybutyrate. Arch Intern Med
199915922214.
22
Alcohol
  • Can reduce effectiveness of HARRT by reducing
    adherence.
  • Can lead to hepatotoxicity either directly or
    indirectly by increasing the risk of drug-induced
    hepatotoxicity.
  • Videx (ddI) can increase the risk of
    pancreatitis.
  • Can ?AUC of abacavir by 41 and ?t1/2 by 26.
    Clinical significance?

23
Alcohol
  • Occasional and light use of alcohol is not known
    to interact with other HIV medications however,
    chronic, heavy use can be destructive to the
    liver.

24
Marijuana
  • 3A4,2C9,2C6 substrate
  • Protease inhibitors may increase THC levels (the
    active ingredient in marijuana)let your patients
    know that smaller doses may make them more
    stoned. This is also true of the synthetic
    version (Marinol) used in the treatment of weight
    loss.

25
Cocaine (coke, blow)
  • There are no known interactions between cocaine
    and HIV medications, but in the test tube,
    cocaine doubles the speed at which the virus
    reproduces, meaning it may speed up how sick you
    get.
  • EFV,NVP,RTV may ? hepatotoxic metabolite.

26
LSD (acid, blotters)
  • No known interactions.

27
Ketamine (Special K, Kit Kat)
  • When combined with Norvir, special K can lead to
    "chemical hepatitis," an unpleasant inflammation
    of the liver resulting in jaundice. A New York
    HIV doctor has seen two cases of it in patients
    on RTV. Both went away in several weeks.
  • Weak inhibitor 2D1 and 3A4
  • PIs likely to ? effect of Ketamine
  • Norvir, Viracept and Sustiva are suspected to
    cause special K to build up in the body and lead
    to toxic shock.

28
Amyl nitrite (Poppers)
  • Glutathione is used by the liver to process amyl
    nitrite, and high glutathione is linked with
    survival. If using amyl nitrite cuts glutathione,
    it could lead to disease progression.

29
PCP (angel dust, morning glory)
  • Metabolized in the liver through oxidative
    hydroxylation, CYP3A4
  • PIs, Rescriptor, and possibly Sustiva work in the
    same liver pathway that PCP is broken down in.
    Taking PCP while using these drugs may result in
    high PCP concentrations.

30
Mushrooms(shrooms, boomers, psilocybin)
  • No known interactions.

31
Methylphenidate (Ritalin)
  • Norvir and other similar drugs can either
    strengthen Ritalin's effects or make it weaker.
    Beware!

32
Heroin (smack, brown, junk, China White)
  • Norvir seems to reduce heroin levels by 50
    making overdose less likely. However, this drug
    and the other protease inhibitors have sometimes
    been known to have opposite effects (they cut
    methadone levels in real life, while test tube
    experiments predicted they would increase them),
    so caution is in order.
  • Some synthetics sold as heroin (fentanyl,
    alpha-methyl-fentanyl) are potent in tiny doses
    and could be deadly if mixed with another drug.

33
Sedatives
  • The sedatives Halcion (triazolam), Valium
    (diazepam), Ambiem (zolpidem) and Versed
    (midazolam) can be deadly if mixed with PIs.
    Norvir has the largest negative effect. At high
    doses these drugs can stop your breathing.
  • Ativan (lorazepam), Serax (oxazepam) and Restoril
    (temazepam) are safer with Norvir, and may
    actually be weakened by it since they are
    glucuronidated and norvir ? glucuronidation.

34
Barbiturates
  • Clinicians should avoid co-administration of
    NNRTIs and phenobarbital.
  • Phenobarbital is a potent inducer of CYP3A4 and
    so are NNRTIs.
  • Crixivan may increase blood levels of
    phenobarbital (Luminal), making overdose more
    likely. Other protease inhibitor interactions are
    also possible.

35
Methadone (done)
  • Interactions between methadone and NNRTIs and PIs
    are highly likely.
  • Sustiva and Viramune strongly induce the
    metabolism of methadone (?AUC 52 and 46
    respectively)and may cause withdrawal in
    methadone pts.
  • People on methadone maintenance may need higher
    doses of the opiate. Ritonavir, nelfinavir, and
    possibly Kaletra may cause similar problems.

36
Methadone (done)
  • Methadone increased the AUC of ZDV by 43 and
    can lead to toxicity. Patients should be
    monitored for toxicity (i.e. nausea, vomiting,
    headaches and low blood platelet levels).
  • Methadone may decrease the anti-HIV action of
    Didanosine (AUC ? 63) while taking methadone.
    This could lead to resistance in the virus and
    the creation of more powerful strains of HIV.
    Using Videx EC is thought to allow the drugs to
    pass through the stomach without methadone
    weakening them.

37
Buprenorphine
  • Drug interaction data limited
  • Metabolism was inhibited by PIs (RTV IDV
    SQV)
  • Efavirenz has been shown to reduce buprenorphine
    plasma concentrations without precipitating
    withdrawal.

38
Disulfiram/Naltrexone
  • Published data limited
  • Naltrexone not likely because it is not
    metabolized by CYP450
  • Disulfiram while possible has not been documented.

39
Management of drug interactions
  • Familarity with ARV pathways
  • Location of information
  • Thorough medication history
  • Maintain high index of suspicion when
  • Decrease VL
  • Side effects
  • Consider TDM

40
Websites Information about drug interactions
  • www.foodmedinteractions.com
  • www.hivatis.org
  • hivinsite.ucsf.edu
  • www.hopkins-aids.edu
  • www.hiv-druginteractions.org
  • medicine.iupui.edu/flockhart
  • www.hivpharmacology.com
  • www.aidsmeds.com

41
Anti-HIV Medications Street Drugs
  • Street drugs are often not what they are sold as,
    they are frequently cut with substances that may
    interact with drugs themselves and their potency
    can vary wildly, even in the same batch. With the
    lack of research in this area, it's better to
    avoid potential interactions if at all possible.
Write a Comment
User Comments (0)
About PowerShow.com